Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
21 October 2021
Study investigating the long-term impact of moderate to severe COVID-19 finds that a large proportion of COVID-19 patients previously admitted to hospital continue to experience intrusive symptoms six months following infection.
15 September 2021
Updated: the project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine was 'highly commended' at the Health Service Journal Awards 2021.
10 June 2021
Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.
8 October 2020
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.
4 September 2020
New Nature Immunology paper finds strong T cell responses in recovered COVID-19 patients